Search

Your search keyword '"Scichilone, Nicola"' showing total 1,109 results

Search Constraints

Start Over You searched for: Author "Scichilone, Nicola" Remove constraint Author: "Scichilone, Nicola"
1,109 results on '"Scichilone, Nicola"'

Search Results

1. Concepts for the Development of Person-Centered, Digitally Enabled, Artificial Intelligence–Assisted ARIA Care Pathways (ARIA 2024)

2. Long-term inhaled corticosteroid treatment in patients with chronic obstructive pulmonary disease, cardiovascular disease, and a recent hospitalised exacerbation: The ICSLIFE pragmatic, randomised controlled study

4. Profiling severe asthma: Any relevance for age? An analysis from Severe Asthma Network Italy (SANI) cohort

6. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

7. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

9. Precision Medicine in Asthma Therapy

10. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma Treated With Mepolizumab: The REMI-M Study

11. Impairment of EQ-5D-5L Domains According to Allergic Rhinitis and Asthma Control: A MASK-air Real-World Study

12. Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus

14. Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy

15. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

16. The three facets of the SARS-CoV-2 pandemic during the first two waves in the northern, central, and southern Italy

17. Asthma in the digital world

18. Contributors

21. The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study

22. Sustained remission induced by 2 years of treatment with benralizumab in patients with severe eosinophilic asthma and nasal polyposis.

23. The SpO 2 /FiO 2 Ratio Combined with Prognostic Scores for Pneumonia and COVID-19 Increases Their Accuracy in Predicting Mortality of COVID-19 Patients.

24. Are nighttime respiratory symptoms assessed by asthma control test affected by comorbidities?

26. Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

27. Long-Term Clinical and Sustained REMIssion in Severe Eosinophilic Asthma treated with Mepolizumab: The REMI-M study

28. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

29. Diagnostic delay in bronchiectasis: an Italian perspective

30. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

31. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

32. Severe asthma: One disease and multiple definitions

33. Precision Medicine in Asthma Therapy

34. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

35. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

37. Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life

38. Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis:A MASK-air study

39. Exacerbation Burden in COPD and Occurrence of Mortality in a Cohort of Italian Patients: Results of the Gulp Study

40. Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI)

44. Features of severe asthma response to anti-IL5/IL5r therapies: identikit of clinical remission

48. The Severe Asthma Network in Italy: Findings and Perspectives

49. Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study

50. Shadow cost of oral corticosteroids-related adverse events: A pharmacoeconomic evaluation applied to real-life data from the Severe Asthma Network in Italy (SANI) registry

Catalog

Books, media, physical & digital resources